Literature DB >> 26843270

Home management of INR in the public health system: feasibility of self-management of oral anticoagulation and long-term performance of individual POC devices in determining INR.

Sabrina da Silva Saraiva1, Fernanda Andrade Orsi2,3, Marcos Pereira Santos1, Tania Machado1, Silmara Montalvão1, Carolina Costa-Lima1, Erich Vinícius de Paula1,4, Marina Pereira Colella1, Joyce Annichino-Bizzacchi1,4.   

Abstract

The home prothrombin time/international normalized ratio (PT/INR) self-management could be convenient for patients, enhancing treatment compliance and improving the quality of the oral anticoagulation. However, patient self-management (PSM) of oral anticoagulation may not be feasible for up to half of the patients due to cognitive or educational issues. In the present study, we aimed to evaluate the feasibility of a PSM program in a public health medical center that provides care for low-income patients. We also aimed to determine the accuracy of individual point-of-care devices (CoaguChek XS(®)) during long-term of home manipulation. Patients' time-in-therapeutic range (TTR) and perception of quality of life, were evaluated at scheduled study-visits to the center. Additionally, the accuracy of individual CoaguChek XS(®) was evaluated in comparison to the standard automated coagulometer at scheduled study-visits to the center. Twenty-five patients were included in the PSM program. The median TTR of patients was 75 % before inclusion, 72 % at 3 months, 75 % at 6 months and 100 % at 12 months after the beginning of self-management (P = 0.14).The median DASS scores were 64, 63, 61.5 and 71.5 before inclusion and at 3, 6 and 12 months, respectively (P = 0.09). One hundred paired INR values were obtained. Correlation between INR values delivered by individual CoaguChek XS(®) and the automated coagulometer was 94 % and the mean result bias was 0.07 INR units. The coefficient of correlation and the mean bias between methods was stable during 24 months of follow-up. The present study suggests that PSM is feasible for patients treated in the public health system and that the results delivered by CoaguChek XS(®) have long-term reliability.

Entities:  

Keywords:  Management; Oral anticoagulation; Point-of-care; Quality control; Time in therapeutic range

Mesh:

Substances:

Year:  2016        PMID: 26843270     DOI: 10.1007/s11239-016-1335-6

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  34 in total

Review 1.  Self-management of oral anticoagulant therapy: a systematic review and meta-analysis.

Authors:  Thomas D Christensen; Søren P Johnsen; Vibeke E Hjortdal; J Michael Hasenkam
Journal:  Int J Cardiol       Date:  2006-08-07       Impact factor: 4.164

2.  An evaluation of patient self-testing competency of prothrombin time for managing anticoagulation: pre-randomization results of VA Cooperative Study #481--The Home INR Study (THINRS).

Authors:  Rowena J Dolor; R Lynne Ruybalid; Lauren Uyeda; Robert G Edson; Ciaran Phibbs; Julia E Vertrees; Mei-Chiung Shih; Alan K Jacobson; David B Matchar
Journal:  J Thromb Thrombolysis       Date:  2010-10       Impact factor: 2.300

3.  Performance of a point-of-care device in determining prothrombin time in an anticoagulation clinic.

Authors:  Marina P Colella; Maiara M L Fiusa; Fernanda L A Orsi; Erich V de Paula; Joyce M Annichino-Bizzacchi
Journal:  Blood Coagul Fibrinolysis       Date:  2012-03       Impact factor: 1.276

4.  Economic evaluation of the use of point-of-care devices in patients with long term oral anticoagulation.

Authors:  Sophie Gerkens; Jeannine Gailly; Caroline Obyn; Stephan Devriese; Irina Cleemput
Journal:  J Thromb Thrombolysis       Date:  2012-10       Impact factor: 2.300

Review 5.  Self-monitoring and self-management of oral anticoagulation.

Authors:  Josep M Garcia-Alamino; Alison M Ward; Pablo Alonso-Coello; Rafael Perera; Clare Bankhead; David Fitzmaurice; Carl J Heneghan
Journal:  Cochrane Database Syst Rev       Date:  2010-04-14

6.  Economic evaluation of a randomized controlled trial of pharmacist-supervized patient self-testing of warfarin therapy.

Authors:  J Gallagher; S Mc Carthy; N Woods; F Ryan; S O' Shea; S Byrne
Journal:  J Clin Pharm Ther       Date:  2014-10-08       Impact factor: 2.512

7.  Effect of home testing of international normalized ratio on clinical events.

Authors:  David B Matchar; Alan Jacobson; Rowena Dolor; Robert Edson; Lauren Uyeda; Ciaran S Phibbs; Julia E Vertrees; Mei-Chiung Shih; Mark Holodniy; Philip Lavori
Journal:  N Engl J Med       Date:  2010-10-21       Impact factor: 91.245

Review 8.  Home monitoring of anticoagulation.

Authors:  Julie Hambleton
Journal:  J Thromb Thrombolysis       Date:  2003 Aug-Oct       Impact factor: 2.300

9.  A method to determine the optimal intensity of oral anticoagulant therapy.

Authors:  F R Rosendaal; S C Cannegieter; F J van der Meer; E Briët
Journal:  Thromb Haemost       Date:  1993-03-01       Impact factor: 5.249

10.  Performance of a point-of-care device in determining prothrombin time in supra-therapeutic INRs.

Authors:  V A M Hashimoto; E V De Paula; M P Colella; M M Luz Fiusa; S A L Montalvao; T F G S Machado; F A Orsi; J M Annichino-Bizzacchi
Journal:  Int J Lab Hematol       Date:  2012-11-22       Impact factor: 2.877

View more
  1 in total

1.  Hematocrit Self-Testing in Patients with Polycythemia Vera and Other Hematological Conditions: Assessing the Accuracy of the StatStrip Xpress® 2 LAC/Hb/Hct Device and User Opinion about the Device in Real-World Clinical Practice.

Authors:  Alicia Rovó; Claudia Baierlein-Leimbach; Cesare Medri; Ioannis Chanias; Loreen Errass; Theresa Fehr; Therese Triemer; Daphne B McCarthy-Pontier; Thomas Lehmann
Journal:  J Clin Med       Date:  2022-07-21       Impact factor: 4.964

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.